BioCellChallenge From Delivery to discovery

Laurent Meunier, PhD   

CEO and Founder

Laurent Meunier has been involved in drug delivery systems since 1995. He obtained his PhD in Cellular and Molecular Biology and Biophysics from the university of Orléans (France) in 1999 where he worked on intracellular antisense oligonucleotides delivery and trafficking. He spent 3 years at the St Jude Children's Research Hospital in Memphis (TN, USA) where he conducted a project about the chaperone proteins organization inside the endoplasmic reticulum and their role in the immunoglobulins folding. He came back to France in 2003 to manage project on the HIV envelope protein before joining a biotechnology company in the South of France as R&D Manager. He developed then several intracellular efficient drug delivery systems during those last years. In 2009, he brings together the adapted skill to create the Biotechnology company BioCellChallenge.

Stéphane Moutard, PhD

Chemistry R&D Manager

Stéphane Moutard obtained his PhD in Organic Chemistry from the CEA (French Atomic Energy Commission) and the University of Picardie (Amiens, France) in 2003. He worked on synthesis, physico-chemical characterizations and biological studies of novel amphiphilic cyclodextrin-based glycolipids and their pharmaceutical compositions. These drug delivery systems were evaluated to transport molecules through the Hemato-Encephalic-Barrier. He conducted then an industrial project on chemical modifications of natural water-soluble polysaccharides (guar gum) for petroleum recovery operations or/and cosmetic applications. In 2005, he joined a biotechnology start-up company as R&D Chemistry Manager, where he developed innovative molecules as efficient intracellular drug delivery vectors. He gained a strong experience in organic chemistry, especially in lipid chemistry, and published several patents and papers.

Vincent Delauzun, Engineer

Biology R&D Manager

Vincent Delauzun has been graduated in 2002 from the National Polytechnic Institute of Lorraine in bio-engineering. He worked in several virology laboratories before he spent 3 years at the Gustave Roussy Institute of Cancerology (Villejuif, France) where he worked on genetic predisposition of cancer diseases. He joined in 2006 a drug delivery systems specialized company where he gained a strong experience in intracellular delivery reagents discovery.

Martine Pillot